Promoter hypermethylation of DLC-1, a candidate tumor suppressor gene, in several common human cancers

Cancer Genetics and Cytogenetics

Volumn 140, Issue 2, 2003, Pages 113-117

  Yuan, Bao Zhu ^a   Durkin, Marian E ^b   Popescu, Nicholas C ^a  

^a NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; DNA; ENZYME;

ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CANCER GENETICS; COLON CARCINOMA; DEMETHYLATION; DNA METHYLATION; GENE DELETION; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CARCINOMA; SOUTHERN BLOTTING; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; AZACITIDINE; BASE SEQUENCE; BREAST NEOPLASMS; CARCINOMA, HEPATOCELLULAR; COLONIC NEOPLASMS; CPG ISLANDS; DNA METHYLATION; DNA, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; LIVER NEOPLASMS; MALE; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; NEOPLASMS; PROMOTER REGIONS (GENETICS); PROSTATIC NEOPLASMS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0037438985     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(02)00674-X     Document Type: Article

References (25)

1. Yuan B.Z., Miller M.J., Keck C.L., Zimonjic D., Thorgeirsson S.S., Popescu N.C. Cloning, characterization and chromosomal localization of a gene frequently deleted in human liver cancer (DLC-1) homologous to rat RhoGAP. Cancer Res. 58:1998;2196-2199.
2. Homma Y., Omori Y. A dual functional signal mediator showing RhoGAP and phospholipase C-d stimulating activities. EMBO J. 14:1995;286-291.
3. Wang D.Z., Nur-E-Kamal M.S., Tikoo A., Montague W., Maruta H. The GTPase and Rho GAP domains of p190, a tumor suppressor protein that binds the M(r) 120,000 Ras GAP, independently function as anti-Ras tumor suppressors. Cancer Res. 57:1997;2478-2484.
4. Sahai E., Olson M.F., Marshall C.J. Cross-talk between Ras and Rho signalling pathways in transformation favours proliferation and increased mobility. EMBO J. 20:2001;755-766.
5. Arbieva Z.H., Banerjee K., Kim S.Y., Edassery S.L., Maniatis V.S., Horrigan S.K., Westbrook C.A. High-resolution physical map and transcript identification of a prostate cancer deletion interval on 8p22. Genome Res. 10:2000;244-257.
6. Xu J., Zheng S.L., Hawkins G.A., Faith D.A., Kelly B., Isaacs S.D., Wiley K.E., Chang B., Ewing C.M., Bujnovszky P., Carpten J.D., Bleecker E.R., Walsh P.C., Trent J.M., Meyers D.A., Isaacs W.B. Linkage and association studies of prostate cancer susceptibility. Evidence for linkage at 8p22-23 Am J Hum Genet. 69:2001;341-350.
7. Zitzelsberger H., Lehmann L., Werner M., Bauchinger M. Comparative genomic hybridisation for the analysis of chromosomal imbalances in solid tumours and haematological malignancies. Histochem Cell Biol. 108:1997;403-417.
8. Martinez-Climent J.A., Vizcarra E., Sanchez D., Blesa D., Marugan I., Benet I., Sole F., Rubio-Moscardo F., Terol M.J., Climent J., Sarsotti E., Tormo M., Andreu E., Sallido M., Ruiz M.A., Prosper F., Siebert R., Dyer M.J.S., Garcia-Conde J. Loss of a novel tumor suppressor gene locus at chromosome 8p is associated with leukemic mantle cell lymphoma. Blood. 98:2001;3479-3482.
9. Yuan B.Z., Thorgeirsson S.S., Eyfjord J., Gudmundsdottir K., Popescu N.C. Genomic deletion, and DNA hypermethylation of DLC-1, a candidate tumor suppressor gene in several human solid tumors. Proc Am Assoc Cancer Res. 41:2000;105.
10. Wilson P.J., McGlinn E., Marsh A., Evans T., Arnold J., Wright K., Biden K., Young J., Wainwright B., Wicking C., Chenevix-Trench G. Sequence variants of DLC1 in colorectal and ovarian tumours. Hum Mutat. 15:2000;156-165.
11. Ng I.O., Liang Z.D., Cao L., Lee T.K. DLC-1 is deleted in primary hepatocellular carcinoma and exerts inhibitory effects on the proliferation of hepatoma cell lines with deleted DLC-1. Cancer Res. 60:2000;6581-6584.
12. Yuan B.-Z., Zhou X., Durkin M.E., Zimonjic D.B., Gumundsdottir K., Eyfjord J., Thorgeirsson S.S., Popescu N.C. DLC-1 gene exhibits cancer cell growth with in vivo tumorigenicity. Oncogene. in press:2002.
13. Herman J.G. Hypermethylation of tumor suppressor genes in cancer. Semin Cancer Biol. 9:1999;359-367.
14. Merlo A., Herman J.G., Mao L., Lee D.J., Gabrielson E., Burger P.C., Baylin S.B., Sidransky D. 5′ CPG island methylation is associated with transcriptional silencing of the tumour supressor P16/CDKN2/MTS1 in human cancers. Nat Med. 1:1995;686-692.
15. Jones P.L., Wolffe A.P. Relationships between chromatin organization and DNA methylation in determining gene expression. Semin Cancer Biol. 9:1999;339-347.
16. Costello J.E., Fruhwald M.C., Smiraglia D.J., Rush L.J., Robertson S.P., Gao S., Wright F.A., Feramisco J.D., Peltomaki P., Lang J.C., Schuller D.E., Yu L., Bloomfield C.D., Caligiuri M.A., Yates A., Nishikawa R., Su H.H., Petrelli N.J., Zhang X., O'Soriso M.S., Held W.A., Cavenee W.K., Plass C. Aberrant CpG-island methylation has nonrandom and tumour-type-specific patterns. Nat Genet. 24:2000;132-138.
17. Esteller M., Corn P.G., Baylin S.B., Herman J.G. A gene hypermethylation profile of human cancer. Cancer Res. 61:2001;3225-3229.
18. Durkin M.E., Yuan B.Z., Thorgeirsson S.S., Popescu N.C. Gene structure, tissue expression, and linkage mapping of the mouse DLC-1 gene (Arhgap 7). Gene. 288:2002;119-127.
19. Cross S.H., Charlton J.A., Nan X., Bird A.P. Purification of CpG islands using a methylated DNA binding column. Nat Genet. 6:1994;236-244.
20. Yin X.L., Pang J.C., Ng H. Identification of a region of homozygous deletion on 8p22-23.1 in medulloblastoma. Oncogene. 21:2002;1461-1468.
21. Bachman K.E., Herman J.G., Corn P.G., Merlo A., Costello J.F., Cavenee W.K., Baylin S.B., Graff J.R. Methylation-associated silencing of the tissue inhibitor of metalloproteinase-3 gene suggest a suppressor role in kidney, brain, and other human cancers. Cancer Res. 59:1999;798-802.
22. Dammann R., Li C., Yoon J.H., Chin P.L., Bates S., Pfeifer G.P. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nat Genet. 25:2000;315-319.
23. Ueki T., Walter K.M., Skinner H., Jaffee E., Hruban R.H., Goggins M. Aberrant CpG island methylation in cancer cell lines arises in the primary cancers from which they were derived. Oncogene. 21:2002;2114-2117.
24. Young K.T., Jong S.H.S., Song S.H., Dimtchev A., Jeong S.J., Kim T., You Kim N.K., Jung M., Bang Y.J. Hyper-methylation of the HP/DLC-1 CpG island is associated with transcriptional silencing of HP/DLC-1 in human gastric cancer cells. Proc Am Assoc Cancer Res. 43:2002;1127.
25. Bina M., Crowely E. Sequence patterns defining the 5′ boundary of human genes. Biopolymers. 59:2001;347-355.